MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion
MindWalk Holdings Corp. (NASDAQ: HYFT) secured a binding commitment for a $30 million unsecured credit facility from Sanabil (Cayman). The facility has a 7.00% fixed interest rate, a 36-month term, and no equity dilution. Funds will support biologics programs and commercial expansion. The agreement is expected to close within 60 days.
How this was made

The 30-second read
Why it matters
The unsecured credit line provides flexible capital for R&D and commercial rollout without equity dilution, which could be viewed positively by shareholders seeking growth financing.
Market read
A new $30 M debt facility for a micro‑cap biotech may modestly influence HYFT's share price and reflects broader financing trends in AI‑driven life‑science firms.
What to watch
Potential covenant‑free structure may attract investors seeking upside without immediate dilution.
Background
MindWalk Holdings Corp. (NASDAQ: HYFT) is a Bio‑Native AI company developing AI‑driven biologics platforms.
Ticker impact
MindWalk announced a binding $30 million senior unsecured revolving credit facility with a 7% fixed rate.
Modest upside if market views the financing as growth‑enabling; slight downside risk from added leverage.
Credit facilities of this size are material for a micro‑cap biotech, but the amount is modest relative to typical financing needs.
Market effects
May signal increased financing activity in AI‑enabled biotech sector.
Limited to US biotech investors; no broader regional effect.
Minimal global impact beyond niche biotech investors.
Counterpoint
The facility could be a sign of cash constraints, suggesting dilution risk if additional financing is needed later.
Key entities
- companyMindWalk Holdings Corp.
Issuer of the credit facility.
- companySanabil (Cayman)
Lender providing the revolving credit facility.



